Publicaciones en colaboración con investigadores/as de Hospital Universitario de Salamanca (4)

2020

  1. Phase III study to evaluate patient’s preference of subcutaneous versus intravenous trastuzumab in HER2-positive metastatic breast cancer patients: Results from the ChangHER study (GEICAM/2012-07)

    European Journal of Cancer Care, Vol. 29, Núm. 4

2019

  1. The Medical Oncology resident mentor: situation and workload

    Clinical and Translational Oncology, Vol. 21, Núm. 3, pp. 304-313

2017

  1. New clinical trials regulation in Spain: analysis of royal decree 1090/2015

    Clinical and Translational Oncology, Vol. 19, Núm. 3, pp. 291-300

2008

  1. A Phase II study of weekly vinorelbine and trastuzumab in patients with HER2-positive metastatic breast cancer

    Clinical Breast Cancer, Vol. 8, Núm. 3, pp. 264-268